News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
150,904 Results
Type
Article (7307)
Company Profile (23)
Press Release (143574)
Multimedia
Podcasts (1)
Webinars (3)
Section
Business (53498)
Career Advice (354)
Deals (9444)
Drug Delivery (7)
Drug Development (19883)
Employer Resources (18)
FDA (3703)
Job Trends (3893)
News (84855)
Policy (6522)
Tag
Academia (498)
Accelerated approval (1)
Adcomms (5)
Allergies (32)
Alliances (7395)
ALS (25)
Alzheimer's disease (284)
Antibody-drug conjugate (ADC) (33)
Approvals (3766)
Artificial intelligence (44)
Autoimmune disease (8)
Automation (1)
Bankruptcy (55)
Best Places to Work (3332)
BIOSECURE Act (4)
Biosimilars (25)
Biotechnology (16)
Bladder cancer (28)
Brain cancer (9)
Breast cancer (99)
Cancer (703)
Cardiovascular disease (62)
Career advice (329)
Career pathing (5)
CAR-T (21)
Cell therapy (78)
Cervical cancer (11)
Clinical research (17101)
Collaboration (154)
Compensation (91)
Complete response letters (2)
COVID-19 (613)
CRISPR (8)
C-suite (32)
Cystic fibrosis (13)
Data (816)
Depression (12)
Diabetes (79)
Diagnostics (1384)
Digital health (5)
Diversity, equity & inclusion (6)
Drug discovery (18)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (30)
Earnings (38639)
Editorial (7)
Employer branding (2)
Employer resources (15)
Events (21120)
Executive appointments (78)
FDA (4122)
Frontotemporal dementia (2)
Funding (129)
Gene editing (21)
Generative AI (5)
Gene therapy (73)
GLP-1 (214)
Government (879)
Grass and pollen (2)
Guidances (124)
Healthcare (4290)
Huntington's disease (4)
IgA nephropathy (8)
Immunology and inflammation (45)
Indications (15)
Infectious disease (656)
Inflammatory bowel disease (39)
Inflation Reduction Act (1)
Influenza (12)
Intellectual property (23)
Interviews (48)
IPO (5848)
IRA (4)
Job creations (744)
Job search strategy (315)
Kidney cancer (3)
Labor market (15)
Layoffs (121)
Legal (1205)
Liver cancer (17)
Lung cancer (110)
Lymphoma (52)
Machine learning (1)
Management (7)
Manufacturing (48)
MASH (23)
Medical device (3162)
Medtech (3162)
Mergers & acquisitions (3752)
Metabolic disorders (189)
Multiple sclerosis (24)
NASH (5)
Neurodegenerative disease (17)
Neuropsychiatric disorders (8)
Neuroscience (414)
NextGen: Class of 2025 (1348)
Non-profit (913)
Now hiring (1)
Obesity (93)
Opinion (26)
Ovarian cancer (25)
Pain (22)
Pancreatic cancer (27)
Parkinson's disease (37)
Partnered (5)
Patents (52)
Patient recruitment (25)
Peanut (23)
People (7094)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase I (4313)
Phase II (7234)
Phase III (6849)
Pipeline (771)
Policy (18)
Postmarket research (786)
Preclinical (1553)
Press Release (9)
Prostate cancer (41)
Psychedelics (6)
Radiopharmaceuticals (99)
Rare diseases (72)
Real estate (969)
Recruiting (5)
Regulatory (4948)
Reports (15)
Research institute (445)
Resumes & cover letters (40)
Rett syndrome (2)
RNA editing (2)
RSV (19)
Schizophrenia (19)
Series A (20)
Series B (11)
Service/supplier (1)
Sickle cell disease (12)
Special edition (12)
Spinal muscular atrophy (42)
Sponsored (4)
Startups (487)
Stomach cancer (3)
Supply chain (8)
Tariffs (9)
The Weekly (1)
Vaccines (204)
Venture capitalists (7)
Weight loss (53)
Women's health (5)
Worklife (1)
Date
Today (9)
Last 7 days (373)
Last 30 days (908)
Last 365 days (9052)
2025 (3270)
2024 (9453)
2023 (10669)
2022 (12589)
2021 (13394)
2020 (12173)
2019 (10318)
2018 (7684)
2017 (10866)
2016 (5959)
2015 (7912)
2014 (5565)
2013 (3712)
2012 (4117)
2011 (4301)
2010 (4210)
Location
Africa (268)
Alabama (8)
Alaska (1)
Arizona (28)
Arkansas (2)
Asia (9137)
Australia (1362)
California (1655)
Canada (586)
China (162)
Colorado (83)
Connecticut (65)
Delaware (57)
Europe (23375)
Florida (193)
Georgia (69)
Idaho (8)
Illinois (128)
India (5)
Indiana (96)
Iowa (1)
Japan (51)
Kansas (30)
Kentucky (2)
Louisiana (5)
Maine (30)
Maryland (197)
Massachusetts (1170)
Michigan (53)
Minnesota (97)
Mississippi (1)
Missouri (17)
Montana (6)
Nebraska (2)
Nevada (32)
New Hampshire (18)
New Jersey (575)
New Mexico (1)
New York (506)
North Carolina (292)
North Dakota (1)
Northern California (771)
Ohio (30)
Oregon (2)
Pennsylvania (390)
Puerto Rico (4)
Rhode Island (1)
South America (359)
South Carolina (4)
Southern California (664)
Tennessee (17)
Texas (211)
United States (6111)
Utah (44)
Virginia (30)
Washington D.C. (9)
Washington State (135)
Wisconsin (14)
150,904 Results for "17".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT Annual Combined General Meeting of June 17, 2025 — Availability of Preparatory Documents
May 8, 2025
·
5 min read
Mergers & acquisitions
Novartis Drops up to $1.7B to Bolster Oligo Pipeline With Regulus Buy
At the heart of the acquisition is Regulus’ farabursen, an miRNA-targeting oligonucleotide in early-stage development for rare autosomal dominant polycystic kidney disease.
April 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
SBC Medical to Present at the Emerging Growth Conference on April 17, 2025
April 9, 2025
·
3 min read
Press Releases
Polyrizon Ltd. Announces $17.0 Million Private Placement
April 1, 2025
·
5 min read
Earnings
Pfizer Announces Another $1.7B in Cost Savings, Including R&D Revamp
Pfizer’s R&D organization has been in flux for almost two years now, since the $43 billion acquisition of ADC specialist Seagen. The new cuts were revealed in the company’s Q1 earnings report.
April 29, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Evotec SE to Announce Results for Financial Year 2024 on 17 April 2025
April 10, 2025
·
3 min read
Press Releases
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
April 14, 2025
·
3 min read
Press Releases
SOTIO Unveils Promising Preclinical Data on SOT109, a Next-Gen ADC Targeting Cadherin-17 (CDH17) for Colorectal Cancer
March 4, 2025
·
3 min read
Press Releases
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
April 25, 2025
·
6 min read
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 17, 2025
April 18, 2025
·
4 min read
1 of 15,091
Next
